Contract 75N94023F00001
Boston Medical Center Corporation · Department Of Health And Human Services · October 12, 2022
Boston Medical Center Corporation was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on October 12, 2022 for $69.37 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Boston, MA. This is a task or delivery order issued under parent IDIQ 75N94020D00004. The contract has been modified 196 times since the base award It uses cost no fee contract pricing. The most recent modification was on April 21, 2026.
Contract details
- PIID
- 75N94023F00001
- Parent IDIQ
- 75N94020D00004
- Award type
- Delivery Order
- Pricing
- Cost No Fee
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Boston, MA
- First action
- October 12, 2022
- Latest action
- April 21, 2026
Description
NICHD: R&D: OVAPRENE VAGINAL DEVICE CLINICAL TRIAL PHASE 1: NON-SEVERABLE
Modification timeline
-
April 21, 2026Mod P00004$-12.7K
-
April 10, 2026Mod P00007SUPPORT SERVICES FOR HIV AIDS CLINICAL TRIAL NETWORKS$2.39M
-
March 26, 2026Mod P00003NICHD: R&D: MANAGEMENT, ADMINISTRATION, AND DATABASE CORE FUNCTION ACTIVITIES: SEVERABLE$336.3K
-
March 23, 2026Mod P00004NICHD: R&D: THE PRENATAL AND CHILDHOOD MECHANISMS OF HEALTH DISPARITIES; INITIAL RECRUITMENT AND RETENTION: NON-SEVERABLE THE PURPOSE OF THIS MODIFICATION IS$0
-
February 23, 2026Mod P00004NICHD:R&D: OVAPRENE PHASE 1: PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE$-1.8K
-
January 30, 2026Mod P00003NICHD: R&D: THE PRENATAL AND CHILDHOOD MECHANISMS OF HEALTH DISPARITIES; INITIAL RECRUITMENT AND RETENTION: NON-SEVERABLE$0
-
January 30, 2026Mod P00009EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI BILATERAL MODIFICATION TO DESCOPE -- NICHD: R&D: "SUPPORT SERVICES FOR THE HIV AIDS CLINICAL TRIAL NE$1.08M
-
January 13, 2026Mod P00002NICHD: R&D: THE PRENATAL AND CHILDHOOD MECHANISMS OF HEALTH DISPARITIES; INITIAL RECRUITMENT AND RETENTION: NON-SEVERABLE$909.7K
-
December 8, 2025Mod P00002OVAPRENE PHASE 1: PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVI$-6.1K
-
November 26, 2025Mod P00003NICHD: R&D: OVAPRENE VAGINAL DEVICE CLINICAL TRIAL: NON-SEVERABLE FY22 CAN 8054183$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | The Boeing Company | 1 | $4.44B |
| 2 | Advanced Technology International | 9 | $3.35B |
| 3 | Amgen USA Inc | 2 | $774.69M |
| 4 | Siga Technologies, Inc. | 1 | $624.44M |
| 5 | Icon Government And Public Health Solutions, Inc. | 16 | $404.80M |
| 6 | Technical Resources International, Inc. | 19 | $395.29M |
| 7 | Allucent Government Services (Us) Llc | 9 | $384.26M |
| 8 | Mapp Biopharmaceutical, Inc. | 7 | $354.24M |
| 9 | Ppd Development Lp | 18 | $331.02M |
| 10 | Albert B. Sabin Vaccine Institute, Inc. (The) | 2 | $305.87M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N94023F00001?
Contract 75N94023F00001 is a federal contract awarded to Boston Medical Center Corporation by Department Of Health And Human Services on October 12, 2022 for $69.37 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 196 times since the base award.
Who won contract 75N94023F00001?
Boston Medical Center Corporation won contract 75N94023F00001 from Department Of Health And Human Services.
How much is contract 75N94023F00001 worth?
Contract 75N94023F00001 has obligated $69.37 million to date.